Advertisement
UK markets closed
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • CRUDE OIL

    83.80
    +0.99 (+1.20%)
     
  • GOLD FUTURES

    2,344.50
    +6.10 (+0.26%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,781.03
    +589.53 (+1.15%)
     
  • CMC Crypto 200

    1,397.32
    +14.74 (+1.07%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Is This The Turning Point for Inovio?

Is This The Turning Point for Inovio?

It seems such a long time ago that Inovio Pharmaceuticals (NASDAQ: INO) was considered one of the leaders in the hunt for a COVID-19 vaccine -- but the biotech was left in the dust by peers and many investors have given up on the stock. In the past 12 months, shares of Inovio are down 45% even as the broader market took off. Let's see whether the company is finally ready to turn things around.